Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

82 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Pharma Patents In The Pandemic

    In 2020, the number of international patent applications filed via WIPO continued to grow amid the COVID-19 pandemic, and currently there is a noticeable renewed interest in vaccine and antibody-related patents.
    DenmarkIntellectual Property
    Aera A/S
    Aera A/S
  • Article

    Ny Rapport: Kopivarer Koster Kassen

    Kopivarer koster årligt kosmetik-, legetøjs- og tøjindustrien i EU 16 milliarder euro i tabt omsætning.
    DenmarkIntellectual Property
    Patrade
    Patrade
  • Article

    The Eastern High Court Upholds Sonion's Preliminary Injunction Against Huawei And Sony

The Eastern High Court finds that Huawei and Sony infringe Sonion's patent and utility model rights, upholding the preliminary injunction granted by the Maritime and Commercial High Court.
DenmarkIntellectual Property
Plesner
Plesner
  • Article

    Design Registration: The Optimal Way To Protect Your Design

    Companies invest heavily in visual identity, but without proper protection, that investment remains vulnerable. Design registration offers a practical approach to safeguarding product appearance by focusing on novelty and individual character, making it essential to consider protection early and align filing strategies with target markets.
    European UnionIntellectual Property
    Aera A/S
    Aera A/S
  • Video

    How Budde Schou Patent Attorneys Use Qthena To Improve Work Quality And Reduce Costs (Video)

    Steen Wadskov-Hansen, CEO of Budde Schou, reveals how his Scandinavian IP law firm has integrated Qthena AI into daily patent workflows, transforming everything from searches...
    GlobalIntellectual Property
    Questel
    Questel
  • Article

    The UPC Leaves Pre-grant DNI Question Open – The Court Of Appeal In Omnia v Sidel

    The Unified Patent Court's Court of Appeal has ruled on a critical procedural question: can a declaratory non-infringement action be brought before a European patent is granted? In Omnia v Sidel, the court examined whether the UPC has competence to hear such actions and distinguished between competence and admissibility in patent litigation.
    DenmarkIntellectual Property
    Bech-Bruun
    Bech-Bruun
  • Article

    G2/22 Is Good News For Patentees

    A lot of people have commented on the recently issued decision in consolidated cases G 1/22 and G 2/22 from the Enlarged Board of Appeal of the European Patent Office (EBA).
    DenmarkIntellectual Property
    Aera A/S
    Aera A/S
  • Article

    The Danish Maritime And Commercial High Court Grants Bristol-Myers Squibb A Preliminary Injunction Against Teva

    The Danish Maritime and Commercial High Court rules on complex matters of patent-law concerning the right to claim priority in accordance with G 1/22 and G 2/22 and the right to include post published data following G 2/21...
    DenmarkTransport
    Plesner
    Plesner
  • Article

    EPO Enlarged Board Clarifies: Publicly Available Products Are Prior Art, Even If Irreproducible

    The European Patent Office's Enlarged Board has fundamentally altered the landscape of prior art assessment, establishing that products made publicly available before a patent filing date constitute prior art regardless of whether they can be analyzed or reproduced. This landmark decision removes the long-standing reproducibility requirement, making market availability alone sufficient to destroy novelty and significantly raising the stakes for timely patent filings.
    European UnionIntellectual Property
    Aera A/S
    Aera A/S
  • Article

    Post-Filing Of Evidence To Support Patent Claims?

    The identification of new chemical or medical compounds, and the development of complex clinical schemes for treatment requires heavy investments and is very time-consuming.
    DenmarkIntellectual Property
    Aera A/S
    Aera A/S
  • Article

    Fundraising Now Begins With An FTO

    Freedom-to-operate (FTO) used to be the analysis a life-science company commissioned before a product launch or a sale. Public funders have moved it to the top of the list — and where they have led, private capital is following.
    DenmarkIntellectual Property
    Aera A/S
    Aera A/S
  • Article

    Skinny Labelling – A “Loophole” Under Pressure?

    Recent U.S. case law is reshaping the risks around skinny labelling strategies for generics. What was once seen as a safe regulatory pathway now raises new concerns about infringement
    DenmarkIntellectual Property
    Aera A/S
    Aera A/S
  • Article

    Central Division (Munich), February 24, 2026, Decision, UPC_CFI_829/2024

    The Court construed the coposition as claimed in claim 1 of the Patent as comprising a range of marker molecule calculated in respect of the total sugar composition...
    DenmarkIntellectual Property
    Bardehle Pagenberg
    Bardehle Pagenberg
  • Article

    Hvordan får man patent på software?

    Antallet af computerimplementerede opfindelser er inde i en rivende udvikling og vi får mange henvendelser om patentering.
    DenmarkIntellectual Property
    Patrade
    Patrade
  • Article

    Part 2: Theme: Focus On Leniency

    The leniency rules allow undertakings having entered into unlawful cartel agreements to apply for leniency relief in the form of exemption from or reduction of fines.
    DenmarkAntitrust/Competition Law
    Bech-Bruun
    Bech-Bruun
  • Article

    Kan man tage patent på et navn?

    It can be difficult to keep track of the various intellectual property rights if you do not work with IPR on a daily basis.
    DenmarkIntellectual Property
    Patrade
    Patrade
  • Article

    Playing Loose – CJEU Asked To Decide On Combination SPCs

    The EU Court of Justice faces a pivotal decision on whether medicines approved as monotherapy but labeled for use in combination with other drugs qualify for Supplementary Protection Certificate (SPC) protection as combinations of active ingredients. This referral, stemming from Genmab's attempts to secure SPC protection for loose combinations including daratumumab, could resolve over a decade of legal uncertainty and fundamentally reshape how pharmaceutical companies approach regulatory strategy for combin
    DenmarkIntellectual Property
    HGF Law
    HGF Law
  • Article

    Intellectual Property Rights

    Intellectual property rights are intellectual property rights and include patent rights, utility models, copyrights, trademark rights and design rights, among others.
    DenmarkIntellectual Property
    Clemens
    Clemens
  • Article

    Why IP Matters In Biochar: Protecting And Commercialising Innovation In Europe's Fastest Growing Carbon Removal Sector

    Biochar has rapidly shifted from a niche soil amendment to a key climate technology, with Europe expanding from 20 production plants in 2015 to more than 200 by 2024 as demand...
    DenmarkIntellectual Property
    Potter Clarkson LLP
    Potter Clarkson LLP
  • Article

    New American Patent Act — Important Also For Danish Companies

    On 16 September 2011, President Obama signed the Leahy-Smith America Invents Act after its adoption by both chambers of Congress.
    DenmarkIntellectual Property
    Bech-Bruun
    Bech-Bruun
  • Showing 61–80 of 82 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics